Management of idiopathic pulmonary arterial hypertension in a patient in Trinidad: A case report
Dalip, Dominic
Dalip, Dominic
Abstract
Abnormal elevation in pulmonary arterial blood pressure without secondary causes is Idiopathic Pulmonary Arterial Hypertension (IPAH). It is imperative to establish this diagnosis because IPAH often progresses to right heart failure (RHF) and death without treatment. Right heart catheterization is the standard gold test for diagnosing pulmonary hypertension (PH); however, echocardiography is a susceptible sensitive test and the best non-invasive test. The overall management of IPAH involves supportive measures, conventional therapy, and, pending availability, PAH-targeted therapy. Upon review of the literature, there were no published case reports on IPAH in Trinidad and Tobago. We describe a case of IPAH presented at Apley Medical Centre Limited, Trinidad and Tobago, in the West Indies, emphasizing contemporary management, including using the Implantable Delivery Systems (IDS) for Remodulin injection.
MIDER Authors
Citations
Altmetric:
Date
2022-09-28
Type
Article
Subject
Conventional therapy, Idiopathic pulmonary arterial hypertension, Implantable delivery system, Pah-targeted therapy, Primary pulmonary hypertension, Remodulin injection, Sildenafil, Treprostinil
Collections
Citation
Mohan, N., Dalip, D., & Jaggernauth, S. (2022). Management of Idiopathic Pulmonary Arterial Hypertension in a Patient in Trinidad: A Case Report. Cureus, 14(9), e29699. https://doi.org/10.7759/cureus.29699